| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $51.8M | -14.6% |
| Cost of Revenue | $29.2M | -18.3% |
| Gross Profit | $22.5M | -9.1% |
| R&D Expense | $9.5M | -19.6% |
| SG&A Expense | $12.2M | -4.0% |
| Operating Income | -$8.5M | +5.0% |
| Pre-tax Income | -$6.4M | +28.1% |
| Income Tax | $73K | +148.0% |
| Net Income | -$6.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.4M | -13.5% |
| Accounts Receivable | $12.8M | +9.5% |
| Inventory | $3.6M | -9.4% |
| Current Assets | $25.8M | -0.3% |
| Total Assets | $45.3M | -6.4% |
| Current Liabilities | $13.0M | -3.8% |
| Total Liabilities | $17.0M | -2.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.1M | +68.4% |
| Capital Expenditures | $166K | -6.7% |
| Investing Cash Flow | -$389K | -118.5% |
| Financing Cash Flow | $350K | -91.9% |
| Free Cash Flow | -$1.3M | +65.5% |
| +26.0% |
| EPS (Basic) | -$0.54 | +31.6% |
| EPS (Diluted) | -$0.54 | +31.6% |
| Stockholders' Equity |
| $28.3M |
| -8.7% |